Navigation Links
CSA Medical Selected to Present at AdvaMed 2010: The MedTech Conference
Date:10/7/2010

BALTIMORE, Oct. 7 /PRNewswire/ -- Following a highly selective application process, CSA Medical, Inc. (www.CSAmedical.com) has been selected to present the company's background, progress and future plans for its proprietary spray cryotherapy platform on Tuesday, October 19, 2010 at AdvaMed 2010. The presentation will take place from 10:20-10:50 am at the Walter E. Washington Convention Center in Washington, D.C.

CSA Medical is first to harness the power of extreme cold, liquid nitrogen (-196 C), therapeutic energy delivery inside the body. This unique technology (device, catheter and agent) allows delivery of therapeutic doses of a cryogen to destroy diseased tissue inside the body while preserving the stromal matrix. This cell death with scaffolding preservation is unique to liquid nitrogen spray cryotherapy. Financial highlights, product development and commercialization plans for CSA Medical's novel Spray Cryotherapy technology will be overviewed during the presentation.

"We are looking forward to a busy and exciting meeting as our schedule is full with strategic partner and investor meetings," said Steve Schaefer, the company's President and CFO. "CSA Medical addresses the expanding need for minimally invasive treatment options.  Patients and physicians want clinically effective therapy with less pain and morbidity and quick recovery when possible.  Patented, spray cryotherapy delivers on these needs as evidenced by the growing number of users and procedures performed."

AdvaMed is the national trade association for medical device, diagnostic and heath information system companies. These companies manufacture 90% of the health care technology produced annually in the United States and 50% globally. The annual MedTech conference will attract over 1,400 business leaders, entrepreneurs, policy-makers, media, financiers, and other industry stakeholders from around the world including 500+ CEOs, Presidents and C-level executives.

CSA Medical, Inc. develops and manufactures a proprietary therapeutic interventional platform, the CryoSpray Ablation™ System.  The CSA System utilizes a patented spray cryogenic technology that allows a physician to freeze and destroy a wide range of unwanted tissues via an endoscope.

For more information, please contact Richard Hughen at rhughen@csamedical.com or www.CSAmedical.com.Contact: Richard HughenCSA Medical, Inc.Phone: (443) 921-8053Fax: (866) 641-5157rhughen@csamedical.com
'/>"/>

SOURCE CSA Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Globus Medical Raises $110 Million in Series E Financing Round
5. Quark Pharmaceuticals Appoints New Chief Medical Officer
6. Boston University Biomedical Engineers Find Chink in Bacterias Armor
7. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
8. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
9. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
10. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
11. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... , Maharashtra, February 12, 2016 ... research report titled Chronic Inflammation Global Clinical Trials ... snapshot of the global clinical trials landscape along ... trials by Region, Country (G7 & E7), Trial ... status and reviews top companies involved and enlists ...
(Date:2/11/2016)... Feb. 11, 2016 Stem cells are primitive ... by self-renewal and the capacity to differentiate into mature ... discovery, as the first mouse embryonic stem cells were ... until 1995 that the first culturing of embryonic stem ... were not produced until 2006 As a result of ...
(Date:2/11/2016)... 11, 2016  Kindred Biosciences, Inc. (NASDAQ: KIN ... the lives of pets, today announced the submission to ... Animal Drug Application (NADA) for Zimeta™ (dipyrone injection, KIND-012).  ... of Zimeta for the control of pyrexia (fever) in ... --> --> The Chemistry, Manufacturing, ...
Breaking Medicine Technology:
(Date:2/12/2016)... Pa. (PRWEB) , ... February 12, 2016 , ... Every ... heaters. , This winter the West Penn Burn Center, part of the ... Company #1, to bring you the “Space Heaters Need Space” campaign. ...
(Date:2/12/2016)... ... February 12, 2016 , ... The Jones Agency, a ... across eastern Texas, is launching a cooperative charity drive with the Tarrant Area Food ... more than 50,000 individuals and families in need, the Tarrant County Food Bank offers ...
(Date:2/12/2016)... , ... February 12, 2016 , ... ... the Pittsburgh metro area, celebrates the beginning of the latest charity campaign in ... social skills through art. Donations to this worthy cause are currently being accepted ...
(Date:2/12/2016)... , ... February 12, 2016 , ... For Coast Dental ... Suzan Sweeney, RDH, and dental assistant Terrell Moore shortly before 7 a.m. to volunteer ... of dental professionals, donating their time and skills to help hundreds of uninsured and ...
(Date:2/12/2016)... ... February 12, 2016 , ... Nearly every health website and ... These articles generally list between five and 15 foods that should be consumed ... one of these lists and believes that nutritious eye healthy foods are extremely ...
Breaking Medicine News(10 mins):